Sage Journals: Discover world-class research

Abstract

Study Design:

Systematic review and meta-analysis.

Objectives:

Cervical spinal cord compression (SCC) due to degenerative changes of the spine is a frequent finding on magnetic resonance imaging (MRI). While most people remain asymptomatic, a proportion develop symptoms of degenerative cervical myelopathy (DCM). DCM is an often-progressive neurological disease that can cause quadriplegia. The epidemiology of SCC and DCM is poorly understood. We sought to estimate the prevalence of degenerative cervical SCC and DCM from cross-sectional cohorts undergoing MRI.

Methods:

We conducted a systematic review and meta-analysis of MRI reports on human subjects older than 16 years with degenerative SCC. A predetermined search strategy was used to identify relevant literature on MEDLINE. Title and abstract screenings were followed by full text screening. Data was extracted and analyzed by fixed or random-effects models.

Results:

The present search returned 1506 publications. Following our exclusion criteria, 19 studies were included. Subgroup analysis of 3786 individuals estimated the prevalence of asymptomatic SCC in a healthy population as 24.2% with a significantly higher prevalence of SCC in older populations compared with younger populations and American/European populations compared with Asian populations. Subgroup analysis of 1202 individuals estimated the prevalence of DCM in a healthy population as 2.3%.

Conclusions:

We present the first estimates of the prevalence of asymptomatic SCC and DCM. Studies investigating the epidemiology of SCC are heterogeneous in methodology and results. These data indicate the need for more studies into the epidemiology of SCC and DCM performed with consistent methodologies.

Keywords

degenerative cervical myelopathy cervical myelopathy spondylosis spondylotic stenosis disc herniation ossification posterior longitudinal ligament spinal cord compression magnetic resonance imaging prevalence incidence

Introduction

Cervical spinal cord compression (SCC) due to degeneration of the cervical spine is a frequent finding on magnetic resonance imaging (MRI).^1
-3 Degenerative changes include spondylosis, degenerative disc disease, ligamental hypertrophy, and ossification of the posterior longitudinal ligament.⁴ SCC mainly occurs during later stages of life and in most cases remains asymptomatic.^5
-7 Nevertheless, a subset of individuals will develop symptoms, causing a condition that has recently been termed degenerative cervical myelopathy (DCM).^4,8

DCM is a heterogeneous disease with symptoms ranging from mild sensory or motor disturbances to loss of bladder control and tetraplegia.^9,10 It has a severe impact on quality of life with SF-36 (Short Form–36) scores comparable to or worse than many other chronic diseases.¹¹ Moderate/severe and worsening forms of DCM require surgical decompression.^12

-15 Surgery is able to arrest disease progression and provide limited functional improvement.^14,16 The average age of patients undergoing surgical decompression is in the mid-50s.¹⁶ However, DCM patients often face long delays in diagnosis and treatment, which in turn lead to increased disability.¹⁷

Delayed diagnosis and treatment may be a consequence of a lack of awareness by the general public and health professionals, lack of resources in the form of access to necessary imaging, the absence of dedicated patient pathways, and inadequate access to relevant health professionals. A better understanding of the epidemiology of asymptomatic SCC and DCM is necessary to adequately address the existing problems, optimize recognition and treatment, and consequently reduce disability.

SCC is a necessary but not sufficient prerequisite for the development of DCM. There is no direct relationship between the degree of SCC and the severity of DCM symptoms.¹⁸ Indeed, reported rates of progression from asymptomatic SCC to DCM of at least 1.8% per year indicate that SCC usually does not cause DCM.^5
-7 The prevalence of SCC has been investigated in multiple studies using cervical MRI scans (Figure 1), but no systematic review or meta-analysis of these studies has been undertaken so far. A previous narrative analysis suggested a prevalence of SCC of 4.9% to 13% in the general population, but this study only assessed 5 studies.¹⁸ Present information with regard to the prevalence of DCM largely derives from surgical cohort studies, which underestimate the true prevalence since only a subset of DCM patients undergo surgery.¹⁹

Figure 1.

Search strategy used in MEDLINE.

The objectives of this study were to estimate the pooled prevalence of SCC and DCM in healthy adult populations to arrive at a more reliable epidemiological estimate. We also aimed to highlight any shortcomings in the existing data. We aimed to identify cross-sectional studies reporting the prevalence of SCC or DCM. This systematic review is the first quantitative analysis of pooled studies investigating SCC or DCM.

Methods

Search Strategy and Study Selection

The following search strategy, summarized in Figure 1, was used to identify original research investigating the frequency of SCC or DCM on MEDLINE. Index articles^1,2,20
-22 were screened for keywords, including relevant MeSH terms (Figure 1), and experience from existing reviews adapted.^23

-26 The search was conducted on May 15, 2018. References were exported and subsequently managed using Microsoft Excel. The present review was not registered and the protocol was not made available.

Abstracts and titles of all references were screened (SS) and reviews and case reports were excluded. BD independently assessed title and abstract screening by random selection of 160 abstracts confirming homogeneity. Articles published before 1985 were also excluded because MRI was not in routine clinical use before this point. Articles were included if the title/abstract suggested a clinical study or series reporting on MRI of the cervical spine that may provide information on SCC. A low threshold was used for inclusion in full text screening. Full text articles were screened independently (SS and MS). Articles were included if they met the following criteria: (a) English full text available; (b) participants older than 16 years; (c) clinical study or series reporting on MRI of the cervical spine; (d) distinguishable data on individuals without nondegenerative forms of SCC, for example, cancer, fracture, or inflammatory arthritis; and (e) not diagnosed with DCM prior to study. We did not use sampling method as an inclusion or exclusion criteria in order to maximize the number of studies identified. Studies were included even if the principal aim of that study did not relate to investigating the prevalence of SCC. Disagreements on the inclusion of articles were resolved by consensus, and if necessary, a third author (BMD). In the case of articles using the same original dataset, the article using the most comprehensive data relevant to this review were used. Abstracts and unpublished data were not included. The reference list of articles that met the inclusion criteria were hand searched for extra relevant articles. The authors of 8 articles, which were excluded during full text screening as they did not report data on the frequency of SCC but who may have such data, were contacted. No new data was obtained by this method. These included studies that reported the frequency of SCC by intervertebral level.

Data Extraction

An extraction tool was piloted and iteratively developed using a random subset of included articles (BMD and SS). Data items included demographic data such as gender, age and study location, sample size, frequency of SCC, the presence of T2 hyperintensity and the presence of symptoms. DCM was defined as the presence of at least one sign/symptom of DCM²⁷ in the presence of degenerative SCC. The inclusion criteria and the definition of SCC used in each study was also collected, along with MRI protocol data—specifically the imaging techniques used, the magnetic field strength of the MRI scanner, slice thickness, and the number of reviewers who analyzed the collected data (Supplementary Table S1). SS extracted data by identifying each data element in the full text of all included articles.

Quality and Bias Assessment

SS and MS assessed the risk of bias within studies using 6 of the 10 criteria developed by Hoy et al²⁸ that were determined to be of relevance (Supplementary Figure S1). Studies found to have high bias (scoring 5 or 6) were excluded from analysis. The risk of bias across studies was not assessed. SS and MS assessed the quality of each study using a set of 9 criteria (Supplementary Figure S2), based on the Joanna Briggs Institute Prevalence Critical Appraisal tool.²⁹ These criteria evaluated sample selection and representativeness, as well as statistical methods; each study was assigned a quality score between 0 and 9.

The GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach was used to score the quality of the prevalence estimates.³⁰ Each estimate was scored as very low-, low-, moderate-, or high-quality evidence. Because the included studies were observational, we initially scored the evidence as low quality and modified this based on the risk of bias, directness of evidence, consistency of results, and risk of publication bias.

Data Analysis

Data was analyzed in Microsoft Excel using a premade meta-analysis spreadsheet with the equation to calculate the Q statistic P value added.³¹ Information on the sample size and the number of affected individuals was inserted for each study. To assess heterogeneity between studies, we calculated the Cochran Q statistic and calculated the I² value to quantify the magnitude of heterogeneity. Before data analysis, it was decided that a fixed-effects model would be used if the Q statistic P value was >.05; if statistically significant heterogeneity was identified a random effects model would be used. Data from studies that investigated healthy and unhealthy participants was treated separately for analysis purposes. To enable inclusion of studies identifying no individuals with SCC in the meta-analysis a continuity correction of 0.1 was added to such studies. Continuity correction was deemed appropriate as only 3 of 23 datasets identified no individuals with SCC.³² The following subgroups were defined prior to analysis: pretest probability of SCC, age, location, gender, year of study, MRI strength, MRI slice thickness, and the number of reviewers. Differences between subgroups were compared using the mean and standard deviation for each group. Statistical analysis was performed using the same Excel spreadsheet as above.

Results

Study Selection

The selection process is summarized as a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram in Figure 2. The initial search identified 1506 articles and abstract screening eliminated 1243 studies. Full text screening of the remaining 263 articles identified 29 eligible articles. A reference hand screen identified 2 more eligible studies leaving 31 articles providing distinguishable data on the frequency of SCC that were considered for meta-analysis. A high risk of bias resulted in 12 articles being excluded from further analysis.^{33

-45} Consequently, 19 articles from 10 countries were included in the present analysis^{1
-3,5,20,46

-59} (Table 1).

Figure 2.

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram. A total of 1506 articles were screened for relevance, and 19 studies were included in this review. Thirteen studies that met the inclusion criteria were excluded due to a high risk of bias.

Table 1.

Details of the 19 Included Studies.^a

Author(s)	Year	Healthy /unhealthy	Percentage healthy with SCC (SE)	Percentage unhealthy with SCC (SE)	Definition of SCC	Percentage with DCM	Quality score (/9)	Risk of bias	Country	Age, y, mean (SE)	Sampling method	Target population	Exclusion criteria
Adamova et al	2015	78/78	57.7 (8.6)	84.6 (5.2)	Subjective		5	Moderate	Czech Republic	66	Healthy participants selected by by 3-level method intentional sampling, consecutive patients	Patients with lumbar stenosis, balanced age and gender of healthy volunteers	Patients with single level spine disease
Brauge et al	2015	50/0	20 (6.3)		Subjective		6	Low	France	41	Selected through French Rugby Union	Former rugby players	Neurological symptoms or spinal disease
Heffez et al	2004	0/270		23 (2.9)	Quantitative		4	Moderate	USA	44	Nonrandom	Patients with fibromyalgia	Unclear
Hehir et al	2012	0/31		22.6 (8.5)	Not defined		3	Moderate	USA	54	Consecutive	Clinical and electrophysiological criteria for C8 radiculopathy	Any other neurological disease
Holman	2008	0/69		21.7 (5.6)	Quantitative		4	Moderate	USA	50	Consecutive	Suspected fibromyalgia	Unclear
Houten et al	2008	0/31		64.5 (14.4)	Subjective	64.5	3	Low	USA	?	Consecutive	Hoffman sign positive patients with low back pain/lower limb pain	Previous neurosurgery
Karki et al	2015	0/750		5.7 (0.9)	T2H		3	Low	Nepal	45	Consecutive	Clinical indication for cervical MRI	Incomplete clinical examination or acute symptoms
Kerkovsky et al	2012	15/0	13.3 (9.4)		Not defined		5	Low	Czech Republic	57	Unclear	Hospital employees	Neurological disease
Kovalova et al	2016	183/0	59 (5.7)		Subjective	1.1	8	Moderate	Czech Republic	66	Census	Caucasians in South Moravia	Cervical surgery or trauma
Laimi et al	2007	22/47	0	0	Not defined		7	Low	Finland	17	Census	All 17-year-old schoolchildren in a single city	Nil
Martin et al	2018	42/0	52.4 (11.2)		Quantitative	4.8	5	Moderate	Canada	45	Convenience	Unclear	Neurological symptoms
Matsumoto et al	1998	497/0	7.6 (1.2)		Not defined		7	Moderate	Japan	40	Convenience	Unclear	Neurological symptoms or spinal disease
Nagata et al	2012	977/0	24.4 (1.6)		Subjective	2.8	7	Low	Japan	66	Census	Japanese in urban coastal and mountainous regions	Cervical surgery or poor image quality
Nakashima et al	2016	1211/0	5.3 (0.7)		Quantitative		6	Moderate	Japan	50	Advertisement recruited volunteers	Japanese	Cervical surgery or trauma, neurological disease or symptoms
Smorgick et al	2015	0/1615		5.1 (0.6)	T2H	5.1	2	Moderate	Israel	61	Consecutive	Clinical indication for cervical MRI	Unclear
Sung et al	2001	0/16		93.8 (24.2)	Subjective	93.8	2	Moderate	USA	47	Consecutive	Patients with spinal complaint presenting to clinic	Nil
Takao et al	2013	607/30	6.8 (0.9)	90 (17.3)	Quantitative		4	Moderate	Japan	68	Consecutivefor patients, unclear regarding healthy controls	Patients with spinal injury without fracture, and healthy volunteers	Patients without prior spinal disease, and healthy volunteers without neurological symptoms or surgery
Tejus et al	2015	4/320	0	75 (15.3)	Subjective		3	Moderate	India	43	Consecutive for patients, unclear regarding healthy participants	Patients with neck related complaints and healthy controls	Neurosurgery or major trauma
Teresi et al	1987	100/0	7 (2.7)		Subjective		2	Moderate	USA	50	Consecutive	Patients undergoing MRI for laryngeal symptoms	Neurological symptoms

^a Details included the year of publication, the number of healthy (people with no symptoms or diagnosed diseases) or unhealthy (people with symptoms or diagnosed disease) individuals, the percentage of each of these individuals with spinal cord compression (SCC) or degenerative cervical myelopathy (DCM). Furthermore, the definition of SCC was categorized as subjective (defined based on subjective decisions such as a defect in the contour of the spinal cord), quantitative (defined based on quantitative decisions such as a spinal canal diameter <8 mm), not defined or T2H (defined by identifying magnetic resonance imaging [MRI] scans with T2-hyperintensity and then looking for SCC). The country the study took place in is also recorded. The risk of bias and quality scores are also given; higher scores equate to higher quality.

Study Characteristics

Of the 19 studies, 11 provided information on healthy individuals, 6 provided data on individuals with symptoms not obviously related to the spinal cord and 5 investigated patients diagnosed with diseases other than DCM. These 19 studies involved a total of 6755 individuals, of which 936 (13.86%) had SCC. To assess heterogeneity between studies, Cochran Q and I² statistics were calculated. This yielded an I² value of 97, indicating high heterogeneity. Pooled analysis across all studies was therefore not appropriate. Instead a subgroup analysis was conducted to investigate potential sources of heterogeneity. This revealed that in particular the location of the study, the age of the population imaged, and the presence or absence symptoms influenced the prevalence of SCC. The definition of SCC, the study year, the slice thickness used on MRI and the tesla power of the MRI did not significantly affect rates of SCC. Insufficient studies provided a breakdown on the rate of SCC in men and women to allow gender comparisons. ´

Prevalence of SCC in Healthy and Symptomatic Populations

The first analysis separated studies based on the pretest probability of SCC (Figure 3). This was defined as low (healthy individuals), uncertain (individuals suffering from dizziness, headaches, radiculopathy, laryngeal symptoms or fibromyalgia but not from myelopathic symptoms), or high (individuals with symptoms or signs of DCM or thoracic/lumbar spinal stenosis or traumatic spinal cord injury with no fracture). We defined myelopathic symptoms as those commonly present in DCM (neck or limb pain, weakness, sensory loss, loss of dexterity, paraesthesia, imbalance, falls, and autonomic dysfunction) as defined by Davies et al.⁴ A separate subgroup was formed for studies that sought to identify SCC on the basis of hyperintensity on T2-weighted MRI signaling (T2H), as this definition is likely to be correlated with symptomatic SCC and exclude most cases of asymptomatic SCC.

Figure 3.

Subgroup analysis of spinal cord compression (SCC) prevalence based on the pretest probability of SCC. The low pretest group contained healthy individuals with no known symptoms or disease. The uncertain pretest probability group contained individuals with symptoms or diseases not thought to be directly related to degenerative cervical myelopathy (DCM). These included individuals suffering from dizziness, headaches, radiculopathy, or fibromyalgia. The high pretest probability group included individuals suffering from symptoms or signs of DCM (and hence SCC would be expected) or possible related diseases such as lumbar spinal stenosis and traumatic spinal cord injury without major fracture. This high pretest probability subgroup had a significantly higher prevalence of SCC than any other subgroup.

The asymptomatic/healthy individual subgroup with low pretest probability of SCC consisted of 11 studies with 3686 participants, 568 of whom had SCC. This group consisted only of individuals who had no clinical reason for undergoing cervical MRI. The pooled prevalence using a random effects model was 24.2% (95% CI 12.4-36, low-quality evidence). The I² value was 88.

The uncertain pretest probability subgroup of individuals with nonmyelopathic symptoms involved 5 studies, in which 91 of 517 individuals were found to have SCC. The pooled prevalence using a fixed-effects model was 17.6% (95% CI 10.6-29.8, low-quality evidence). Observed study heterogeneity was low (I² = 0).

The high pretest probability group consisting of individuals with myelopathic symptoms or thoracic/lumbar stenosis involved 5 studies, including 187 patients of whom 152 had SCC. The pooled prevalence using a fixed effects model was 81.3% (95% CI 67-95.6, low-quality evidence). No heterogeneity was observed (I² = 0).

The low and uncertain pretest subgroups were not significantly different (P = .38), but the high pretest probability subgroup had a significantly increased probability of SCC as compared with the low (P = 1.61 × 10⁻⁹) and uncertain pretest probability subgroups (P = 8.47 × 10⁻¹⁴).

The T2 hyperintensity group involved 2 studies, in which 125 of 2365 patients had SCC with T2 hyperintensity. The pooled prevalence using a random effects model was 5.3% (95% CI 1.3-9.3, very low-quality evidence), and study heterogeneity was low (I² = 0). The T2 hyperintensity subgroup was significantly different from the low, uncertain and high pretest probability subgroups (P = .003, .011, 1.46 × 10⁻²³ respectively).

Prevalence of SCC and Age

The high heterogeneity and highly different characteristics in the asymptomatic/healthy subgroup (low pretest probability) prompted us to investigate what factors may explain these findings (Figure 4). We therefore conducted subgroup analyses based on mean age—a young subgroup with a mean age of ≤60 years and an aged subgroup with a mean age of >60 years. The subgroup of <60-year-olds involved 7 studies of 1841 individuals. The pooled prevalence using a fixed-effects model was 7.4% (95% CI 2.8-12, moderate-quality evidence). Heterogeneity I² was 40. The aged, ≥60-year-olds subgroup involved 4 studies. A total of 432 of 1845 participants had SCC. The pooled prevalence using a random-effects model was 35.3% (95% CI 14.1-56.5, low-quality evidence). However, heterogeneity I² increased to 93.9. The prevalence of SCC was significantly higher in the aged subgroup (P = .012).

Figure 4.

Subgroup analysis of the prevalence of spinal cord compression (SCC) in healthy participants separated by age and geographical location. (A) The studies included in the low pretest probability group in Figure 2 were divided based on a mean age of below or above 60 years. The over 60s subgroup had a significantly higher prevalence of SCC than the under 60s subgroup. (B) The studies included in the low pretest probability group in Figure 2 were divided based on the continent the study participants lived in. American/European participants had a significantly higher prevalence of SCCC compared with Asian populations.

Prevalence of SCC in European/American Populations

To assess the possible role of geographical location in SCC variation, we performed a new subgroup analysis on all the low pre-test probability studies. We created 2 groups—American/European and Asian (Figure 4). The American/European subgroup involved 6 studies with 390 individuals. The pooled prevalence using a random-effects model was 39.7% (95% CI 21.0-58.3, low-quality evidence). Study heterogeneity I² was 63.6. The Asian subgroup involved 5 studies and 3296 participants. The pooled prevalence using a random-effects model was 11.1% (95% CI 1.6-20.5, low-quality evidence). Heterogeneity I² was 82.6. The prevalence of SCC was therefore significantly higher in the American/European subgroup than the Asian subgroup (P = .007).

Insufficient data existed for subgroup analysis based on gender. Subgroup analysis for the remaining subgroups identified no difference between subgroups.

Estimation of the Prevalence of DCM

Across the 19 studies, 6 provided data on the presence or absence of DCM. A total 2864 individuals were assessed for DCM symptoms or signs of whom 148 were diagnosed with DCM. The heterogeneity in methodology and target population precluded meta-analysis. The calculated I² value was 90.3. Three of these studies recruited presumed healthy participants and three recruited individuals with signs of DCM who had not been diagnosed with any other disease. Sub-group analysis was performed to separate these groups into low (healthy individuals) and high (signs of DCM) pretest probability groups (Figure 5). The healthy subgroup (low pretest probability) involved 1202 individuals, of which 31 were diagnosed with DCM. The pooled prevalence using a fixed effects model was 2.3% (95% CI 1.4-3.1, low quality evidence). The I² value was 46.4. The DCM subgroup (high pretest probability) involved 1662 individuals, 117 of whom had DCM. However, heterogeneity in the rates of DCM and their methodology in each of these 3 studies prevented meta-analysis.

Figure 5.

Subgroup analysis of the prevalence of degenerative cervical myelopathy (DCM) based on the pretest probability of DCM. The low pretest probability subgroup included individuals who entered their respective studies aware of no symptoms. The high pretest probability subgroup involved individuals who were recruited to the study because of their symptoms.

Risk of Bias Within Studies

The risk of bias in the included studies was low or moderate (Table 1). Thirteen studies had a moderate risk of bias and 6 studies had a low risk of bias.

Discussion

We present the first pooled estimates of the prevalence of SCC from the published literature. Overall, the included studies showed a wide range of prevalence, and therefore only sub-group meta-analysis was deemed possible. The pooled estimate of SCC in the healthy population was 24.2%. However, studies were characterized by high heterogeneity. Using author defined factors to investigate the potential sources of heterogeneity, we identified increasing age (>60 years: 35.3%), European/North American (39.7%) populations or populations with potential symptoms of myelopathy more likely to identify SCC (81.3%). No other investigated factors created subgroups with significantly different rates of SCC.

The investigation of populations with compatible symptoms of myelopathy would be expected to significantly increase the probability of identifying SCC. Nevertheless, the calculated prevalence of over 80%, and the low observed heterogeneity are striking, especially when considering the fact that the symptoms of myelopathy are numerous and overlap with many other related and also unrelated conditions.²⁶ In a series of patients presenting with nontraumatic tetraparesis only 24% had DCM, the leading differential, but this is far from 86%.⁶⁰

The high prevalence of DCM in the presence of myelopathic symptoms raises the following question: Why is DCM often missed as a diagnosis. A potential explanation is the underuse of MRI in patients presenting with symptoms that are compatible with DCM. This points toward the need for developing adequate screening procedures and triaging toward MRI assessment, such as in the case of acoustic neuroma.⁶¹ The fact that healthy populations and populations with non-myelopathic symptoms had comparable levels of SCC was expected and suggests MRI use can be targeted effectively toward at-risk populations.

A separate T2 hyperintensity subgroup was formed due to a differing diagnostic approach in 2 studies. In these studies, first T2 hyperintensity was identified in the spinal cord and then evaluated for the presence of SCC. We justified this decision on the basis that most cases of SCC are not associated with T2 hyperintensity.¹ As a consequence, using T2 hyperintensity to define SCC would exclude many cases of asymptomatic SCC as well as symptomatic DCM patients. Indeed, SCC and T2 hyperintensity was present in only 5.3% of individuals; a significantly lower prevalence than the rate of SCC identified in the other subgroups.

Excluding these symptomatic populations from further analysis, age and study location were found to influence the prevalence of SCC. The association of SCC with increasing age is expected as cervical spondylosis is the consequence of degenerative changes of the spine.⁴ However, the association with location, and especially the fact that Asian populations had a much lower prevalence of SCC compared with American/European populations was somewhat unexpected and is to our knowledge the first time it has been reported in the literature. Interestingly, age was not a confounder in this association. Among the cohort with an average age of greater than 60 years, 2 studies were carried out in Europe (Czech Republic), recording mean SCC rates of 57.7% and 59% and the other 2 studies in Japan, with mean SCC rates of 24.3% and 6.8%, indicating a genetic difference between study populations. It is unclear why American/European populations have a higher prevalence of SCC; indeed Asian individuals are at greater risk of OPLL (ossification of the posterior longitudinal ligament), a condition that often leads to cervical myelopathy.⁶² However, limitations of the currently available data prevent a more conclusive analysis.

A number of studies included in the present analysis identified patients with DCM. Using a fixed-effects model in 3 presumed healthy groups, we found a point prevalence of DCM of 2.3%; roughly 10% of individuals with SCC. The prevalence of DCM identified in the present study is therefore orders of magnitude higher than the operating prevalence of 1.6 per 100 000 previously estimated.¹⁹ There are 2 interpretations of this discrepancy. First, that the prevalence reported in these 3 studies is erroneously high. However, the 3 studies on which this calculation was based received high-quality scores in our assessment and displayed low heterogeneity. The alternate possibility is that DCM is underdiagnosed and/or rarely treated surgically.

The notion that DCM is underdiagnosed is supported by a high incidence (18%) of unrecognized DCM in a small series of patients presenting with a neck of femur fracture.⁶³ Moreover, in the longest observational study of asymptomatic SCC by Bednarik et al,⁶ the likelihood of developing DCM increased over time, with 8% developing DCM after 1 year and 22% with median follow-up of 44 months.^6,7 The high incidence of asymptomatic SCC reported in cross-sectional studies also indicates that the prevalence of DCM is higher than previously estimated.

Not all individuals with DCM require surgery. Recent international guidelines recommend surgery for moderate to severe, or progressive forms of DCM. Surgery can be offered to mild DCM, but structured nonoperative management is also an option.¹² However, our recent retrospective cohort study of patients at a single tertiary hospital found that prior to publication of the guidelines, only half of DCM patients who met the criteria for surgical decompression received surgery in routine practice.¹⁷

There are several limitations to our study. A major limitation was the low number of studies identified; this is especially pertinent for estimating the prevalence of DCM, which was based on 6 articles included in the present analysis. We attempted to increase the number of studies by including populations that were not symptom free. It is possible that relevant information was missed as only a single database was searched for relevant studies (MEDLINE). However, hand-search of references of included articles yielded only 2 articles, suggesting our search strategy identified the majority of relevant studies. Moreover, as far as relevant original research is concerned, MEDLINE indexes and abstracts the ∼4000 journals, which constitute the core clinical literature of biomedicine. Indeed, MEDLINE alone achieves over 90% coverage in an analysis of over 120 systematic reviews.⁶⁴

A further problem in the literature is that there are relatively few large studies (>100 participants) containing original data. While our statistical analysis incorporated study size into its weighting of different studies, this problem with the literature is unavoidable.

A likely source of heterogeneity amongst studies was the varying definition of SCC used. Eight studies used subjective definitions, 5 studies used quantitative definitions, 2 based their definition on T2 hyperintensity, and in 4 studies the definition of SCC was unclear. Even within each subgroup highly different definitions were used; as a result, subgroup analysis could not identify significant differences. Furthermore, many of the studies included were of low quality. The average quality of included studies was 4.5/9, with a range of 2 to 8. While we attempted to rectify this by excluding the studies with a high risk of bias (which were also often low quality), poor and variable methodology may still have contributed to the heterogeneity we observed. The limitations discussed above mean that interpretation of the results should be taken with caution.

Conclusion

This study reports the first pooled estimates of the prevalence of SCC on MRI. We found that approximately 20% of healthy individuals (or individuals with unrelated symptoms) had SCC, and this rose to 86% in populations with myelopathic features. Increasing age and the study location also positively influenced prevalence. The pooled, point prevalence of DCM was 2.3%. However, these findings are based on limited data and further rigorous investigation is required.

Supplemental Material

Supplemental Material, supplementary_figures_sys_review - The Prevalence of Asymptomatic and Symptomatic Spinal Cord Compression on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis

Supplemental Material, supplementary_figures_sys_review for The Prevalence of Asymptomatic and Symptomatic Spinal Cord Compression on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis by Sam S. Smith, Max E. Stewart, Benjamin M. Davies and Mark R. N. Kotter in Global Spine Journal

Footnotes

Author Contributions

SS and BD designed the study. SS and MS collected data. SS performed statistical analysis. SS, BD and MK wrote and reviewed the manuscript.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research in the senior author’s laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. MRNK is supported by a National Institute for Health Research Clinician Scientist Award, CS-2015-15-023, supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.

ORCID iD

Sam S. Smith, BA(Hons)

Supplemental Material

Supplemental material for this article is available online.

References

Kovalova

Kerkovsky

Kadanka

, et al. Prevalence and imaging characteristics of nonmyelopathic and myelopathic spondylotic cervical cord compression. Spine (Phila Pa 1976). 2016;41:1908–1916. doi:10.1097/BRS.0000000000001842

Nagata

Yoshimura

Muraki

, et al. Prevalence of cervical cord compression and its association with physical performance in a population-based cohort in Japan: the Wakayama Spine Study. Spine (Phila Pa 1976). 2012;37:1892–1898. doi:10.1097/BRS.0b013e31825a2619

Nakashima

Yukawa

Suda

Yamagata

Ueta

Kato

. Narrow cervical canal in 1211 asymptomatic healthy subjects: the relationship with spinal cord compression on MRI. Eur Spine J. 2016;25:2149–2154. doi:10.1007/s00586-016-4608-z

Davies

Mowforth

Smith

Kotter

MRN

. Degenerative cervical myelopathy. BMJ. 2018;360:k186.

Martin

De Leener

Cohen-Adad

, et al. Can microstructural MRI detect subclinical tissue injury in subjects with asymptomatic cervical spinal cord compression? A prospective cohort study. BMJ Open. 2018;8:e019809. doi:10.1136/bmjopen-2017-019809

Bednarik

Kadanka

Dusek

, et al. Presymptomatic spondylotic cervical myelopathy: an updated predictive model. Eur Spine J. 2008;17:421–431. doi:10.1007/s00586-008-0585-1

Kadanka

Jr Adamova

Kerkovsky

, et al. Predictors of symptomatic myelopathy in degenerative cervical spinal cord compression. Brain Behav. 2017;7:e00797. doi:10.1002/brb3.797

Nouri

Tetreault

Singh

Karadimas

Fehlings

. Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis. Spine (Phila Pa 1976). 2015;40:E675–E693. doi:10.1097/BRS.0000000000000913

Crandall

Batzdorf

. Cervical spondylotic myelopathy. J Neurosurg. 1966;25:57–66. doi:10.3171/jns.1966.25.1.0057

10.

Tetreault

Karadimas

Wilson

, et al. The natural history of degenerative cervical myelopathy and the rate of hospitalization following spinal cord injury: an updated systematic review. Global Spine J. 2017;7(3 suppl):28S–34S. doi:10.1177/2192568217700396

11.

Lafage

, et al. Comparing quality of life in cervical spondylotic myelopathy with other chronic debilitating diseases using the Short Form Survey 36-Health Survey. World Neurosurg. 2017;106:699–706. doi:10.1016/j.wneu.2016.12.124

12.

Fehlings

Tetreault

Riew

, et al. A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression. Global Spine J. 2017;7(3 suppl):70S–83S. doi:10.1177/2192568217701914

13.

Tetreault

Rhee

Prather

, et al. Change in function, pain, and quality of life following structured nonoperative treatment in patients with degenerative cervical myelopathy: a systematic review. Global Spine J. 2017;7(3 suppl):42S–52S. doi:10.1177/2192568217700397

14.

Fehlings

Tetreault

Kurpad

, et al. Change in functional impairment, disability, and quality of life following operative treatment for degenerative cervical myelopathy: a systematic review and meta-analysis. Global Spine J. 2017;7(3 suppl):53S–69S. doi:10.1177/2192568217710137

15.

Rhee

Tetreault

Chapman

, et al. Nonoperative versus operative management for the treatment degenerative cervical myelopathy: an updated systematic review. Global Spine J. 2017;7(3 suppl):35S–41S. doi:10.1177/2192568217703083

16.

Fehlings

Wilson

Kopjar

, et al. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am. 2013;95:1651–1658. doi:10.2106/JBJS.L.00589

17.

Hilton

Tempest-Mitchell

Davies

Kotter

. Assessment of degenerative cervical myelopathy differs between specialists and may influence time to diagnosis and clinical outcomes. PLoS One. 2018;13:e0207709. doi:10.1371/journal.pone.0207709

18.

Witiw

Mathieu

Nouri

Fehlings

. Clinico-radiographic discordance: an evidence-based commentary on the management of degenerative cervical spinal cord compression in the absence of symptoms or with only mild symptoms of myelopathy. Global Spine J. 2018;8:527–534. doi:10.1177/2192568217745519

19.

Boogaarts

Bartels

RHMA

. Prevalence of cervical spondylotic myelopathy. Eur Spine J. 2015;24(suppl 2):139–141. doi:10.1007/s00586-013-2781-x

20.

Teresi

Lufkin

Reicher

, et al. Asymptomatic degenerative disk disease and spondylosis of the cervical spine: MR imaging. Radiology. 1987;164:83–88. doi:10.1148/radiology.164.1.3588931

21.

Okada

Matsumoto

Ichihara

, et al. Aging of the cervical spine in healthy volunteers: a 10-year longitudinal magnetic resonance imaging study. Spine (Phila Pa 1976). 2009;34:706–712. doi:10.1097/BRS.0b013e31819c2003

22.

Kato

Yukawa

Suda

Yamagata

Ueta

. Normal morphology, age-related changes and abnormal findings of the cervical spine. Part II: magnetic resonance imaging of over 1200 asymptomatic subjects. Eur Spine J. 2012;21:1499–1507. doi:10.1007/s00586-012-2176-4

23.

Davies

McHugh

Elgheriani

, et al. Reported outcome measures in degenerative cervical myelopathy: a systematic review. PLoS One. 2016;11:e0157263. doi:10.1371/journal.pone.0157263

24.

Badran

Davies

Bailey

H-M

Kalsi-Ryan

Kotter

MRN

. Is there a role for postoperative physiotherapy in degenerative cervical myelopathy? A systematic review. Clin Rehabil. 2018;32:1169–1174. doi:10.1177/0269215518766229

25.

Davies

McHugh

Elgheriani

, et al. The reporting of study and population characteristics in degenerative cervical myelopathy: a systematic review. PLoS One. 2017;12:e0172564. doi:10.1371/journal.pone.0172564

26.

Davies

Goh

Kuhn

Kotter

MRN

. Development and validation of a MEDLINE search filter/hedge for degenerative cervical myelopathy. BMC Med Res Methodol. 2018;18:73. doi:10.1186/s12874-018-0529-3

27.

Davies

Munro

Kotter

. A novel insight into the challenges of diagnosing degenerative cervical myelopathy using web-based symptom checkers. J Med Internet Res. 2019;21:e10868. doi:10.2196/10868

28.

Hoy

Brooks

Woolf

, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–939. doi:10.1016/j.jclinepi.2011.11.014

29.

Munn

Moola

Riitano

Lisy

. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123–128. doi:10.15171/ijhpm.2014.71

30.

Guyatt

Oxman

Vist

, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926. doi:10.1136/bmj.39489.470347.AD

31.

Neyeloff

Fuchs

Moreira

. Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52. doi:10.1186/1756-0500-5-52

32.

Sweeting

Sutton

Lambert

. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351–1375. doi:10.1002/sim.1761

33.

Kartal

Yildiran

Senköylü

Korkusuz

. Soccer causes degenerative changes in the cervical spine. Eur Spine J. 2004;13:76–82. doi:10.1007/s00586-003-0623-y

34.

Vavasour

Meyers

MacMillan

, et al. Increased spinal cord movements in cervical spondylotic myelopathy. Spine J. 2014;14:2344–2354. doi:10.1016/j.spinee.2014.01.036

35.

Colledge

Lewis

Mead

Sellar

Wardlaw

Wilson

. Magnetic resonance brain imaging in people with dizziness: a comparison with non-dizzy people. J Neurol Neurosurg Psychiatry. 2002;72:587–589. doi:10.1136/jnnp.72.5.587

36.

Hyman

Edwards

Vacirca

, Stein HL. 0.6 T MR imaging of the cervical spine: multislice and multiecho techniques. AJNR Am J Neuroradiol. 1985;6:229–236.

37.

Fryer

Adams

. Magnetic resonance imaging of subjects with acute unilateral neck pain and restricted motion: a prospective case series. Spine J. 2011;11:171–176. doi:10.1016/j.spinee.2010.12.002

38.

Campi

Pontesilli

Gerevini

Scotti

. Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord. Neuroradiology. 2000;42:669–675.

39.

Lee

Kim

Suk

, et al. Asymptomatic cervical cord compression in lumbar spinal stenosis patients: a whole spine magnetic resonance imaging study. Spine (Phila Pa 1976). 2010;35:2057–2063. doi:10.1097/BRS.0b013e3181f4588a

40.

Jaumard

Udupa

Welch

Winkelstein

. Kinematic magnetic resonance imaging to define the cervical facet joint space for the spine in neutral and torsion. Spine (Phila Pa 1976). 2014;39:664–672. doi:10.1097/BRS.0000000000000206

41.

Girardi

Oppenheim

Steele

, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001;294:605–609. doi:10.1126/science.1063916

42.

Pei

Zhang

Kang

Han

Fan

. Morphological changes of the lower cervical spinal cord under neutral and fully flexed position by MRI in Chinese patients with Hirayama’s disease. Amyotroph Lateral Scler. 2008;9:156–162. doi:10.1080/17482960701726123

43.

Agosta

Lagana

Valsasina

, et al. Evidence for cervical cord tissue disorganisation with aging by diffusion tensor MRI. Neuroimage. 2007;36:728–735. doi:10.1016/j.neuroimage.2007.03.048

44.

Healy

Wong

Olson

. Cervical and lumbar MRI in asymptomatic older male lifelong athletes: frequency of degenerative findings. J Comput Assist Tomogr. 1996;20:107–112.

45.

Ernst

Stadnik

Peeters

Breucq

Osteaux

MJC

. Prevalence of annular tears and disc herniations on MR images of the cervical spine in symptom free volunteers. Eur J Radiol. 2005;55:409–414. doi:10.1016/j.ejrad.2004.11.003

46.

Houten

Noce

. Clinical correlations of cervical myelopathy and the Hoffmann sign. J Neurosurg Spine. 2008;9:237–242. doi:10.3171/SPI/2008/9/9/237

47.

Karki

Gurung

Adhikary

Ghimire

. Magnetic resonance imaging findings in degenerative disc disease of cervical spine in symptomatic patients. J Nepal Health Res Counc. 2015;13:196–200.

48.

Kerkovsky

Bednarik

Dusek

, et al. Magnetic resonance diffusion tensor imaging in patients with cervical spondylotic spinal cord compression: correlations between clinical and electrophysiological findings. Spine (Phila Pa 1976). 2012;37:48–56. doi:10.1097/BRS.0b013e31820e6c35

49.

Laimi

Erkintalo

Metsahonkala

, et al. Adolescent disc degeneration—no headache association. Cephalalgia. 2007;27:14–21. doi:10.1111/j.1468-2982.2006.01233.x

50.

Matsumoto

Fujimura

Suzuki

, et al. MRI of cervical intervertebral discs in asymptomatic subjects. J Bone Joint Surg Br. 1998;80:19–24.

51.

Smorgick

Tal

Yassin

Tamir

Mirovsky

Anekstein

. The relation between location of cervical cord compression and the location of myelomalacia. Skeletal Radiol. 2015;44:649–652. doi:10.1007/s00256-014-2074-4

52.

Sung

Wang

. Correlation between a positive Hoffmann’s reflex and cervical pathology in asymptomatic individuals. Spine (Phila Pa 1976). 2001;26:67–70.

53.

Takao

Morishita

Okada

, et al. Clinical relationship between cervical spinal canal stenosis and traumatic cervical spinal cord injury without major fracture or dislocation. Eur Spine J. 2013;22:2228–2231. doi:10.1007/s00586-013-2865-7

54.

Tejus

Singh

Ramesh

Kumar

VRR

Maurya

Madhugiri

. An evaluation of the finger flexion, Hoffman’s and plantar reflexes as markers of cervical spinal cord compression—a comparative clinical study. Clin Neurol Neurosurg. 2015;134:12–16. doi:10.1016/j.clineuro.2015.04.009

55.

Adamova

Bednarik

Andrasinova

, et al.

Does lumbar spinal stenosis increase the risk of spondylotic cervical spinal cord compression?

Eur Spine J. 2015;24:2946–2953. doi:10.1007/s00586-015-4049-0

56.

Brauge

Delpierre

Adam

Sol

Bernard

Roux

. Clinical and radiological cervical spine evaluation in retired professional rugby players. J Neurosurg Spine. 2015;23:551–557. doi:10.3171/2015.1.SPINE14594

57.

Heffez

Ross

Shade-Zeldow

, et al. Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. 2004;13:516–523. doi:10.1007/s00586-004-0672-x

58.

Hehir

Figueroa

Zynda-Weiss

Stanton

Logigian

. Unexpected neuroimaging abnormalities in patients with apparent C8 radiculopathy: broadening the clinical spectrum. Muscle Nerve. 2012;45:859–865. doi:10.1002/mus.23319

59.

Holman

. Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications. J Pain. 2008;9:613–622. doi:10.1016/j.jpain.2008.01.339

60.

Moore

Blumhardt

. A prospective survey of the causes of non-traumatic spastic paraparesis and tetraparesis in 585 patients. Spinal Cord. 1997;35:361–367.

61.

Robson

Leighton

Anslow

Milford

. MRI as a single screening procedure for acoustic neuroma: a cost effective protocol. J R Soc Med. 1993;86(8):455–457.

62.

Choi

Song

Chang

. Ossification of the posterior longitudinal ligament: a review of literature. Asian Spine J. 2011;5:267–276. doi:10.4184/asj.2011.5.4.267

63.

Radcliff

Curry

Trimba

, et al. High incidence of undiagnosed cervical myelopathy in patients with hip fracture compared with controls. J Orthop Trauma. 2016;30:189–193. doi:10.1097/BOT.0000000000000485

64.

Bramer

Giustini

Kramer

BMR

. Comparing the coverage, recall, and precision of searches for 120 systematic reviews in Embase, MEDLINE, and Google Scholar: a prospective study. Syst Rev. 2016;5:39. doi:10.1186/s13643-016-0215-7

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.12 MB